HomeNews

News

Presenting a Long-due Alternative to More Effectively Treat US’ Ovarian Cancer Problem

AbbVie has officially published its final analysis of the confirmatory Phase 3 MIRASOL trial, which evaluated the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx)...

Funding AI’s Takeover of Drug Discovery

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully raised a sum of $110 million Series E financing. Led by a...

Creating the Ultimate Pharmaceutical Powerhouse Together

Mallinckrodt plc has officially announced that a definitive agreement to merge with Endo in a stock and cash transaction to create one global, scaled,...

Supporting a Drive to Simplify the Complexities of Clinical Documentation

Freed, an AI clinician assistant designed to reduce the burdens of medical documentation, has successfully raised a sum of $30 million in Series A...

Laying Simpler Chain-Links to Expedite the Communication of a Medical Discovery

openRxiv has officially launched as an independent nonprofit to oversee bioRxiv and medRxiv, the world's leading preprint servers for life and health sciences. According to...

Hot Topics